IFF
41
8
CAG
44
13
HP
34
5
TROW
24
3
AIV
37
3
MPC
34
4
SO
62
5
FTI
61
5
HIG
70
2
MAT
26
-8
STX
35
5
RHI
18
-2
LRCX
43
-2
SBUX
33
2
NEE
41
3
EMC
47
5
MUR
27
5
STZ
45
2
CVX
38
6
KSS
7
4
IFF
41
8
CAG
44
13
HP
34
5
TROW
24
3
AIV
37
3
MPC
34
4
SO
62
5
FTI
61
5
HIG
70
2
MAT
26
-8
STX
35
5
RHI
18
-2
LRCX
43
-2
SBUX
33
2
NEE
41
3
EMC
47
5
MUR
27
5
STZ
45
2
CVX
38
6
KSS
7
4
Financhill
Back

SBC Medical Group Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
58

SBC
SBC Medical Group Holdings

Last Price:
$4.20
Seasonality Move:
--
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$53.80
Seasonality Move:
13.2%
Buy
58
SBC Medical Group Holdings (SBC) is a Buy

Is SBC Medical Group Holdings a Buy, Sell or Hold?

  • The current SBC Medical Group Holdings [SBC] share price is $4.02. The Score for SBC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SBC Stock Price Chart

What is SBC Medical Group Holdings's stock price today?

  • The SBC Medical Group Holdings share price today is $4.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SBC is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $53.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 54.93 Buy
Chaikin Money Flow: -8738 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.13 - 3.97) Buy
Bollinger Bands (100): (3.79 - 6.05) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.07 Sell
Relative Strength Index (14 RSI): 31.45 Sell
Chaikin Money Flow: -1452145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.97 - 79.33) Sell
Bollinger Bands (100): (79.54 - 128.22) Sell

SBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.86 Buy
20-day SMA: 3.61 Buy
50-day SMA: 4.06 Sell
200-day SMA: 0 Buy
8-day EMA: 3.95 Buy
20-day EMA: 3.76 Buy
50-day EMA: 4 Buy
200-day EMA: 3.32 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.88 Buy
20-day SMA: 60.79 Sell
50-day SMA: 86.36 Sell
200-day SMA: 118.53 Sell
8-day EMA: 54.47 Sell
20-day EMA: 62.27 Sell
50-day EMA: 80.32 Sell
200-day EMA: 108.23 Sell

SBC Medical Group Holdings Earnings Growth & SBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.26 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

SBC Medical Group Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):